Lyoniresinol 3α-O-β-D-glucopyranoside-mediated hypoglycaemia and its influence on apoptosis-regulatory protein expression in the injured kidneys of streptozotocin-induced mice

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Wen, Qingwei ^a   Liang, Tao ^a   Qin, Feizhang ^a   Wei, Jinbin ^a   He, Qiaoling ^a   Luo, Xiu ^a   Chen, Xiaoyu ^a   Zheng, Ni ^a   Huang, Renbin ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; APOPTOSIS REGULATORY PROTEIN; AVERRHOA CARAMBOLA EXTRACT; BUTANOL; CASPASE 3; CASPASE 8; CASPASE 9; CYCLOHEXANE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYONIRESINOL 3ALPHA O BETA DEXTRO GLUCOPYRANOSIDE 1; LYONIRESINOL 3ALPHA O BETA DEXTRO GLUCOPYRANOSIDE 2; PIOGLITAZONE; PLANT EXTRACT; PLANT GLYCOSIDE; PROTEIN BAX; PROTEIN BCL 2; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; APOPTOSIS; ARTICLE; AVERRHOA CARAMBOLA; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ISOLATION; DRUG STRUCTURE; DRUG TARGETING; EXTRACELLULAR MATRIX; FEMALE; GLOMERULUS; HISTOPATHOLOGY; HYPERGLYCEMIA; KIDNEY HYPERTROPHY; KIDNEY TUBULE BASEMENT MEMBRANE; MALE; MOUSE; NONHUMAN; PLANT ROOT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION;

ANIMALS; ANISOLES; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; FASTING; FEMALE; GENE EXPRESSION REGULATION; HYPOGLYCEMIA; INSULIN; INSULIN RESISTANCE; KIDNEY; MALE; MICE; NAPHTHALENES; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; STREPTOZOCIN;

EID: 84891714776     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081772     Document Type: Article

References (38)

1. Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414: 782-787. doi:10.1038/414782a. PubMed: 11742409.
2. IDF Diabetes atlas-fifth edition. Available: http://wwwidforg/atlasmap/ atlasmap.
3. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4-14. doi:10.1016/j.diabres.2009.10.007. PubMed: 19896746.
4. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH et al. (2006) Epidemic obesity and type 2 diabetes in Asia. Lancet 368: 1681-1688. doi:10.1016/S0140-6736(06) 69703-1. PubMed: 17098087.
5. De Luca C, Olefsky JM (2008) Inflammation and insulin resistance. FEBS Lett 582: 97-105. doi:10.1016/j.febslet.2007.11.057. PubMed: 18053812.
6. Marette A (2003) Molecular mechanisms of inflammation in obesity-linked insulin resistance. Int J Obes 27 Suppl 3: S46-S48. doi:10.1038/sj.ijo.0802500. PubMed: 14704744.
7. Al-Rasheed NM, Willars GB, Brunskill NJ (2006) C-Peptide Signals via Gαi to Protect against TNF-α-Mediated Apoptosis of Opossum Kidney Proximal Tubular Cells. J Am Soc Nephrol 17: 986-995. doi:10.1681/ASN. 2005080797. PubMed: 16510765.
8. Karin M, Delhase M. The; I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling (2000). p. 85.
9. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409-2415. doi:10.1172/JCI117936. PubMed: 7738205.
10. Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L et al. (2004) NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 19: 2505-2512. doi:10.1093/ndt/gfh207. PubMed: 15280531.
11. Gao Z, Hwang D, Bataille F, Lefevre M, York D et al. (2002) Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. J Biol Chem 277: 48115-48121. doi:10.1074/jbc.M209459200. PubMed: 12351658.
12. He Z, Opland DM, Way KJ, Ueki K, Bodyak N et al. (2006) Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. Arterioscler Thromb Vasc Biol 26: 787-793. doi:10.1161/01.ATV. 0000209500.15801.4e. PubMed: 16469952.
13. Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S et al. (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345: 870-878. doi:10.1056/NEJMoa011489. PubMed: 11565519.
14. Verzola D, Gandolfo MT, Ferrario F, Rastaldi MP, Villaggio B et al. (2007) Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 72: 1262-1272. doi:10.1038/sj.ki.5002531. PubMed: 17851466.
15. Fan TJ, Han LH, Cong RS, Liang J (2005) Caspase family proteases and apoptosis. Acta Biochim Biophys Sinica 37: 719-727. doi:10.1111/j.1745-7270. 2005.00108.x. PubMed: 16270150.
16. Slee EA, Adrain C, Martin SJ (2001) Executioner caspase-3,-6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 276: 7320-7326. doi:10.1074/jbc.M008363200. PubMed: 11058599.
17. Liadis N, Murakami K, Eweida M, Elford AR, Sheu L et al. (2005) Caspase-3-dependent β-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol Cell Biol 25: 3620-3629. doi:10.1128/MCB.25.9.3620-3629. 2005. PubMed: 15831467.
18. Oltval ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74: 609-619. doi:10.1016/0092-8674(93)90509-O. PubMed: 8358790.
19. Ranganayaki S, Singh R, Singh AK (1980) The chemical examination of the bark of A. carambola. Proc Natl.. Acad Sci India A 50: 61-63.
20. Wen QW, Lin X, Liu YQ, Xu XH, Liang T et al. (2012) Phenolic and Lignan Glycosides from the Butanol Extract of Averrhoa carambola L. Root. Molecules 17: 12330-12340. PubMed: 23085667.
21. Cazarolli LH, Folador P, Moresco HH, Brighente IM, Pizzolatti MG et al. (2009) Stimulatory effect of apigenin-6-C-beta-L-fucopyranoside on insulin secretion and glycogen synthesis. Eur J Med Chem 44: 4668-4673. doi:10.1016/j.ejmech.2009.07.001. PubMed: 19625113.
22. Cazarolli LH, Folador P, Moresco HH, Brighente IM, Pizzolatti MG et al. (2009) Mechanism of action of the stimulatory effect of apigenin-6-C-(2′- O-alpha-l-rhamnopyranosyl)-beta-L- fucopyranoside on 14C-glucose uptake. Chem Biol Interact 179: 407-412. doi:10.1016/j.cbi.2008.11.012. PubMed: 19070612.
23. Su HC, Hung LM, Chen JK (2006) Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 290: E1339-E1346. doi:10.1152/ajpendo.00487.2005. PubMed: 16434553.
24. Yamashita H, Nagai Y, Takamura T, Nohara E, Kobayashi K-i (2002) Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat. Metabolism 51: 403-408. doi:10.1053/meta.2002.30953. PubMed: 11912544.
25. Zhang M, Lv XY, Li J, Xu ZG, Chen L (2009) The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Experimental. Diabetes Res 2008.
26. Hirasawa Y, Matsui Y, Yamane K, Yabuki S-y, Kawasaki Y et al. (2008) Pioglitazone improves obesity type diabetic nephropathy: relation to the mitigation of renal oxidative reaction. Exp Anim 57: 423-432. doi:10.1538/expanim.57.423. PubMed: 18946178.
27. Maedler K, Schulthess FT, Bielman C, Berney T, Bonny C et al. (2008) Glucose and leptin induce apoptosis in human β-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases. FASEB J 22: 1905-1913. doi:10.1096/fj.07-101824.
28. Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, Burns WC et al. (2002) Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation 106: 246-253. doi:10.1161/01.CIR.0000021122.63813.32. PubMed: 12105166.
29. Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T et al. (2001) The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol 117: 333-340. PubMed: 11511312.
30. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA et al. (2003) β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110. PubMed: 12502499.
31. Weir GC, Bonner-Weir S (2004) Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53: S16-S21. PubMed: 15561905.
32. Donath MY, Gross DJ, Cerasi E, Kaiser N (1999) Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48: 738-744. PubMed: 10102689.
33. Mandrup-Poulsen T (2001) Beta-cell apoptosis: stimuli and signaling. Diabetes 50: S58-S63. doi:10.2337/diabetes.50.2007.S58. PubMed: 11272204.
34. Rudofsky G Jr, Reismann P, Schiekofer S, Petrov D, Eynatten Mv, et; al (2004) Reduction of postprandial hyperglycemia in patients with type 2 diabetes reduces NF-kappaB activation in PBMCs. Horm Metab Res 36: 630-638. doi:10.1055/s-2004-825904. PubMed: 15486815. Available online at: doi:10.1055/s-2004-825904 Available online at: PubMed: 15486815
35. Lehmann R, Schleicher ED (2000) Molecular mechanism of diabetic nephropathy. Clin Chim Acta 297: 135-144. doi:10.1016/S0009-8981(00)00240-0.
36. Gupta S (2001) Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci 69: 2957-2964. doi:10.1016/S0024-3205(01)01404- 7. PubMed: 11758823.
37. Breckenridge DG, Germain M, Mathai JP, Nguyen M, Shore GC (2003) Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 22: 8608-8618. doi:10.1038/sj.onc.1207108. PubMed: 14634622.
38. Talanian RV, Yang X, Turbov J, Seth P, Ghayur T et al. (1997) Granule-mediated killing: pathways for granzyme B-initiated apoptosis. J Exp Med 186: 1323-1331. PubMed: 9334372.